ZFAT

ZFAT is a multi-zinc-finger and AT-hook transcription factor that binds an 8-bp consensus motif (GAA[T/A][C/G]TGC) near transcription start sites and at centromeres, functioning as a transcriptional regulator of hematopoiesis, T cell development, and cell cycle progression (PMID:27591365, PMID:20660741, PMID:41485258). At centromeres, ZFAT is recruited through physical interactions with CENP-B and DAXX and drives centromeric ncRNA transcription by recruiting the acetyltransferase KAT2B to generate H4K8ac, which in turn recruits BRD4 and RNA polymerase II (PMID:32997115, PMID:34547289, PMID:36162510). In T cells, ZFAT directly activates promoters of survival and hematopoietic genes (Bcl-2, Brpf1, IL-7Rα, Tal1, Lmo2, Gata1), controls FoxO1 protein stability through regulation of autophagy and Akt-mediated nuclear exclusion, and sustains TCR-proximal signaling including CD3ζ phosphorylation and ERK/Egr activation during thymocyte positive selection (PMID:20660741, PMID:27226588, PMID:24098453, PMID:22828507). ZFAT is also an essential regulator of the G1/S cell-cycle transition across multiple human cell types (PMID:41485258).

1. 2004 Medium

   A regulatory antisense transcript (SAS-ZFAT) was found to control expression of a truncated ZFAT isoform (TR-ZFAT) in B cells via a functionally validated SNP, establishing that the ZFAT locus is subject to complex cis-regulatory control.

   Evidence In vitro reporter assays and allele-specific expression analysis in peripheral blood lymphocytes

   PMID:15294872

   Open questions at the time

   • No mechanistic link between TR-ZFAT isoform expression and immune cell function
   • Whether antisense regulation operates in cell types beyond B cells is unknown
2. 2008 Medium

   ZFAT was shown to be a nuclear protein whose overexpression alters immune-related gene programs, establishing it as a transcriptional regulator rather than a passive structural protein.

   Evidence Subcellular fractionation and expression array profiling in mouse Ba/F3 cells

   PMID:18329245

   Open questions at the time

   • Direct DNA binding was not demonstrated
   • Mechanism of transcriptional regulation (activator vs. repressor) was unclear
3. 2009 Medium

   ZFAT was identified as a cell survival factor, as its knockdown in T-leukemia cells triggered caspase-dependent apoptosis, revealing an anti-apoptotic role.

   Evidence siRNA knockdown in MOLT-4 cells with caspase activation and viability assays

   PMID:19162026

   Open questions at the time

   • Downstream targets mediating the anti-apoptotic effect were not identified
   • Single cell line
4. 2010 High

   Genetic knockout established ZFAT as essential for primitive hematopoiesis and embryonic survival, with ChIP-PCR demonstrating direct transcriptional control of Tal1, Lmo2, and Gata1 promoters — the first proof of direct DNA binding in vivo.

   Evidence Zfat knockout mice (embryonic lethal) with ChIP-PCR and protein expression analysis; parallel knockdown in MEFs identifying Bcl-2 as a survival target

   PMID:20660741 PMID:21225468

   Open questions at the time

   • Binding motif was not yet defined
   • Genome-wide binding landscape unknown
   • Whether the angiogenesis role (PMID:20645017) connects to hematopoietic transcription program was unclear
5. 2012 High

   T cell-specific conditional knockout revealed that ZFAT is required for peripheral T cell homeostasis by sustaining IL-7Rα expression and IL-7-dependent survival, as well as IL-2Rα induction and proliferation upon TCR stimulation.

   Evidence Conditional KO mice (Zfat f/f-LckCre), flow cytometry, IL-7 survival and TCR stimulation assays

   PMID:22828507

   Open questions at the time

   • Whether ZFAT directly binds the IL-7Rα promoter was not tested
   • Mechanism connecting ZFAT to IL-7Rα transcription was undefined
6. 2013 High

   ZFAT was positioned upstream of TCR-proximal signaling: its loss abolished CD3ζ phosphorylation and ERK/Egr activation in DP thymocytes, causing a positive selection block not rescuable by exogenous TCR, establishing a cell-intrinsic signaling requirement.

   Evidence Conditional KO crossed with TCR-transgenic mice, phospho-flow cytometry, ERK and Egr activity assays

   PMID:24098453

   Open questions at the time

   • How a transcription factor controls CD3ζ phosphorylation is mechanistically unresolved
   • Whether ZFAT regulates CD3ζ expression directly was not tested
7. 2015 High

   NMR structures of 13 individual zinc-finger domains revealed uncommon bulged-out helix structures and a constrained ZF4-ZF5 linker, providing the first structural insight into how ZFAT engages DNA; concurrently, Zfat deficiency was shown to elevate basal p38/JNK signaling and prolong JNK activation after TCR stimulation, broadening the signaling map; and FoxO1 protein (not mRNA) reduction via proteasomal degradation linked ZFAT to IL-7Rα expression through FoxO1 stability.

   Evidence NMR spectroscopy (solution structures); conditional KO with phospho-immunoblotting for p38/JNK/ATF2; proteasome inhibitor rescue of FoxO1 in KO T cells

   PMID:25169027 PMID:25801860 PMID:26168481

   Open questions at the time

   • Which ZF domains mediate DNA recognition of the 8-bp motif was not mapped
   • Proteasomal target (E3 ligase for FoxO1) was not identified
   • How ZFAT suppresses p38/JNK activation is unknown
8. 2016 High

   Genome-wide ChIP-seq defined the ZFAT binding motif and showed preferential TSS occupancy at active chromatin; ZFAT deletion reduced H3K9ac/K27ac at bound promoters, and Brpf1 was validated as a direct target whose loss phenocopies ZFAT deficiency in T cell apoptosis. Simultaneously, FoxO1 degradation in ZFAT-deficient T cells was attributed to enhanced autophagy (reversed by bafilomycin A1/chloroquine) and increased Akt phosphorylation driving FoxO1 nuclear exclusion.

   Evidence ChIP-seq with motif analysis, shRNA Brpf1 knockdown, retroviral rescue; inducible Zfat KO with lysosomal inhibitor rescue, autophagosome quantification, Akt phospho-immunoblotting

   PMID:27226588 PMID:27591365

   Open questions at the time

   • How ZFAT recruits acetyltransferases at gene promoters was not defined
   • Whether Brpf1 mediates ZFAT's effect on histone acetylation was not tested
   • How ZFAT suppresses Akt activation is unknown
9. 2020 High

   ZFAT was shown to bind centromeres genome-wide through its 8-bp motif and to orchestrate a centromeric ncRNA transcription pathway: ZFAT recruits KAT2B → H4K8ac → BRD4 → RNA Pol II, with KAT2B knockdown blocking the entire cascade, establishing a second major genomic locus of ZFAT function beyond gene promoters.

   Evidence ChIP-seq, ChIP-qPCR, KAT2B siRNA epistasis, ncRNA quantification

   PMID:32997115

   Open questions at the time

   • Functional consequence of centromeric ncRNA loss (e.g. on chromosome segregation) was not tested
   • Whether ZFAT uses the same acetyltransferase recruitment mechanism at gene promoters is unknown
10. 2021 High

    The mechanism of ZFAT centromeric targeting was resolved: CENP-B physically interacts with ZFAT (via its acidic domain) and is required for ZFAT centromeric localization and ncRNA production; DAXX was independently shown to interact with ZFAT and further promote its centromeric accumulation.

    Evidence Reciprocal co-IP, ectopic expression, siRNA depletion of CENP-B and DAXX, ChIP, ncRNA quantification

    PMID:34547289 PMID:36162510

    Open questions at the time

    • Whether CENP-B and DAXX act in the same or parallel recruitment pathways is not resolved
    • Domain in ZFAT required for CENP-B and DAXX interaction is unmapped
    • Whether centromeric ncRNA production is functionally relevant to mitosis remains untested
11. 2021 Medium

    ZFAT function was extended beyond immune cells: inducible KO demonstrated a cell-autonomous requirement for ZFAT in adipocyte differentiation and mature adipocyte maintenance, with Atg13 and Brf1 among identified target genes.

    Evidence Inducible Zfat KO mice, ex vivo adipocyte differentiation, triglyceride quantification, RT-PCR

    PMID:33522619

    Open questions at the time

    • Direct promoter binding at adipocyte target genes was not confirmed by ChIP
    • Whether the adipocyte phenotype relates to the autophagy regulation seen in T cells is unexplored
12. 2026 High

    ZFAT was established as an essential G1/S cell-cycle regulator across both transformed and non-transformed human cell lines, demonstrating a conserved proliferative function beyond hematopoietic lineages.

    Evidence siRNA knockdown in four cell lines (HT1080, HCT116, HeLa, RPE1), cell cycle analysis, EdU incorporation, cyclin A2 immunofluorescence, thymidine block synchronization

    PMID:41485258

    Open questions at the time

    • Direct transcriptional targets mediating G1/S control are not identified
    • Whether the cell-cycle role is connected to centromeric function or gene-promoter function is unknown

• Key unresolved questions include: which zinc-finger domains recognize the 8-bp motif; whether the centromeric ncRNA pathway has functional consequences for chromosome segregation or genome stability; how ZFAT suppresses Akt and p38/JNK signaling; the identity of downstream cell-cycle targets driving G1/S transition; and whether the promoter-proximal and centromeric functions of ZFAT are mechanistically linked.
• No structure–function mapping of ZF domains to DNA motif recognition
• No functional readout of centromeric ncRNA loss on mitotic fidelity
• Cell-cycle target genes unidentified
• Integration of centromeric and TSS-proximal functions not addressed